Log In
Print this Print this

Ony-P1, Onyvax-P

  Manage Alerts
Collapse Summary General Information
Company GemVax & Kael Co. Ltd.
DescriptionCell-based vaccine derived from 3 human prostate cancer cell lines
Molecular Target Not available
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Cellular vaccine
Latest Stage of DevelopmentPhase II
Standard IndicationProstate cancer
Indication DetailsTreat castration-resistant prostate cancer (CRPC); Treat prostate cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today